Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liat Ries-Levavi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 13, 2014
Factors that affect the decision to undergo amniocentesis in women with normal Down syndrome screening results: it is all about the ageJulia Grinshpun-Cohen, Talya Miron-Shatz, Liat Ries-Levavi, et al.
Prenatal Diagnosis|August 21, 2007
Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 testsMichal Berkenstadt, Liat Ries-Levavi, Howard Cuckle, et al.
Genetics Research|January 13, 2015
FMR1 CGG allele length in Israeli BRCA1/BRCA2 mutation carriers and the general population display distinct distribution patternsYael Laitman, Liat Ries-Levavi, Michal Berkensdadt, et al.
Journal of Medical Screening|October 25, 2012
Three peaks in the polymerase chain reaction fragile X analysisReuven Sharony, Atalia Shtorch, Aliza Amiel, et al.
The Israel Medical Association Journal : IMAJ|June 26, 2017
Colorectal and Endometrial Cancer Risk and Age at Diagnosis in BLMAsh Mutation CarriersHagit Schayek, Yael Laitman, Lior H Katz, et al.
Journal of Assisted Reproduction and Genetics|August 24, 2018
Preimplantation genetic diagnosis versus prenatal diagnosis-decision-making among pregnant FMR1 premutation carriersLilach Marom Haham, Inbal Avrahami, Noam Domniz, et al.
Human Mutation|March 17, 2004
Genetic and biochemical analyses of Israeli osteogenesis imperfecta patientsLiat Ries-Levavi, Tsofia Ish-Shalom, Moshe Frydman, et al.
Cancer Genetics|January 19, 2016
The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriersYael Laitman, Lital Boker-Keinan, Michal Berkenstadt, et al.
Harefuah|September 4, 2018
[FROM GENETICS OF FRAGILE X SYNDROME TO DEVELOPMENT OF TARGETED AND PERSONALIZED DRUG THERAPY]Lidia V Gabis, Shahar Shefer, Noah Gruber, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 28, 2022
Female fragile X premutation carriers are at increased risk for metabolic syndrome from early adulthoodNoah Gruber, Lilach Marom Haham, Hila Raanani, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 13, 2014
Factors that affect the decision to undergo amniocentesis in women with normal Down syndrome screening results: it is all about the ageJulia Grinshpun-Cohen, Talya Miron-Shatz, Liat Ries-Levavi, et al.
Prenatal Diagnosis|August 21, 2007
Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 testsMichal Berkenstadt, Liat Ries-Levavi, Howard Cuckle, et al.
Genetics Research|January 13, 2015
FMR1 CGG allele length in Israeli BRCA1/BRCA2 mutation carriers and the general population display distinct distribution patternsYael Laitman, Liat Ries-Levavi, Michal Berkensdadt, et al.
Journal of Medical Screening|October 25, 2012
Three peaks in the polymerase chain reaction fragile X analysisReuven Sharony, Atalia Shtorch, Aliza Amiel, et al.
The Israel Medical Association Journal : IMAJ|June 26, 2017
Colorectal and Endometrial Cancer Risk and Age at Diagnosis in BLMAsh Mutation CarriersHagit Schayek, Yael Laitman, Lior H Katz, et al.
Journal of Assisted Reproduction and Genetics|August 24, 2018
Preimplantation genetic diagnosis versus prenatal diagnosis-decision-making among pregnant FMR1 premutation carriersLilach Marom Haham, Inbal Avrahami, Noam Domniz, et al.
Human Mutation|March 17, 2004
Genetic and biochemical analyses of Israeli osteogenesis imperfecta patientsLiat Ries-Levavi, Tsofia Ish-Shalom, Moshe Frydman, et al.
Cancer Genetics|January 19, 2016
The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriersYael Laitman, Lital Boker-Keinan, Michal Berkenstadt, et al.
Harefuah|September 4, 2018
[FROM GENETICS OF FRAGILE X SYNDROME TO DEVELOPMENT OF TARGETED AND PERSONALIZED DRUG THERAPY]Lidia V Gabis, Shahar Shefer, Noah Gruber, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 28, 2022
Female fragile X premutation carriers are at increased risk for metabolic syndrome from early adulthoodNoah Gruber, Lilach Marom Haham, Hila Raanani, et al.
Pageof 2